Haemorheological profile in subjects with nonvalvular atrial fibrillation

Clinical Hemorheology and Microcirculation

Volumn 20, Issue 2, 1999, Pages 85-90

  Caimi, G ^a   Messina, L ^a   Alfano, R ^b   Canincr, B ^a   Fabbiano, A ^a   Cammarata, A M ^b   Lo Presti, R ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

Atrial echocontrast; Atrial fibrillation; Haemorheological determinants

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD FILTRATION; BLOOD FLOW VELOCITY; BLOOD RHEOLOGY; BLOOD VISCOSITY; CLINICAL ARTICLE; FEMALE; HEART ATRIUM FIBRILLATION; HEMATOCRIT; HUMAN; MALE; RISK ASSESSMENT; THROMBOEMBOLISM; THROMBOGENESIS;

AGED; ATRIAL FIBRILLATION; BLOOD VISCOSITY; ERYTHROCYTE AGGREGATION; FEMALE; HEMATOCRIT; HEMORHEOLOGY; HUMANS; MALE; MIDDLE AGED;

EID: 0032940769     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. H. Asakura, S. Hifumi, H. Jokaji, M. Saito. I. Kumahashiri, C. Uotani. E. Morishita, M. Yamaki, K. Shihata and K. Mizuhashi, Prothrombin fragment FI + 2 and thromhin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation, Blood Coagul. Fibrinolysis 3 ( 1992). 469-473.
2. Atrial Fibrillation Investigators, Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials, Arch. Intern. Mcd. 154 (1994), 1449-1457.
3. I.W. Black, C.N. Chesterman, A.P. Hopkins, L.C. Lee, B.H. Chong and W.F. Walsh, Hematologie correlates of left alrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation,. J. Am. Coll. Cartliol. 21 ( 1993), 451457.
4. O.P. Briley, G.D. Giraud. N.B. Beamer, E.M. Spear, S.E. Grauer, J.M. Edwards. W.M. Clark, G.J. Sexton and B.M. Coull, Spontaneous echo contrast and hemorheologic abnormalities in cerebrovascular disease. Stroke 25 ( 1994), 1564-1569,
5. M.D. Esekowitz S.L. Bridgers and K.E. James, Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. New Kngl. J. Med. 327 (1992), 1406-1412.
6. D. Fatkin, E. Herbert and M.P. Feneley, Hematologie correlates of spontaneous echo contrast in patients with atrial fibrillation and implications for thromboembolic risk ,Am. .J. Cimliol. 73 (1994), 672-676.
7. D. Fatkin, R.P. Kelly and M.P. Feneley, Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk m vivo,. J. Am. Coll. Cardiol. 23 ( 1994). 961-969.
8. W.M. Feinberg, J.F. Seeger, R.F. Camody, D.C. Anderson, R.G. Hart and L.A. Pearce, Epidemiologie features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation, Arcli. Inlc'r. Mcd. 150 (1990), 2340-2344.
9. C. Gustafsson, M. Blomback, M. Britton, A. Hamsten and J. Scensson, Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation, Stroke 21(1990), 47-51.
10. G.Y. Lip, P.L. Lip. J. Zarifis, R.D. Watson, D. Bareford, G.D.O. Lowe and D.G. Beevers. Fibrin D-dimer and betathromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultralow-dose warfarin and aspirin, Circulation 94 (1996), 425-431.
11. G.Y.H. Lip, G.D.O. Lowe, A. Rumley and FG. Dunn, Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin therapy, Br. Heart J. 73 (1995), 527-533.
12. G.D.O. Lowe, A.J. Jaap and C.D. Forbcs, Relation of atrial fibrillation and high haematocrit to mortality in acute stroke. Lancet 1 (1983), 784-7X6.
13. R. Mituseh, HJ. Siemens. M. Garbe, T. Wagner, A. Sheikhzadeh and K.W. Diederich, Detection of a hypercoagulable state in novalvular atrial fibrillation and the effect of anticoagulant therapy, Thronh. Haemost. 75 ( 1996), 219-223.
14. P. Petersen, G. Boysen, J. Godtfredsen, E.D. Andersen and R. Andersen, Placebo-controlled, randomised trial of warfarin chronic atrial fibrillation: The Copenhagen AFASAK study. Lancet 1 (1989). 175-179.
15. H.L. Reid, A.J. Barnes, P.J. Locke, J.A. Dormandy and T.L. Dormandy, A simple method for measuring erythrocyte deformability, J. Clin. Palhol 29 (1976), 855-860.
16. H. Schmid-Schönbein, E. Volger, P. Teitel, H. Kiesewetter, V. Dauer and L. Heilmann, New hemorheological techniques for the routine laboratory, Clin. Hemorheol. 2 (1982), 93-105.
17. B. Sigel, J. Machi, J.C. Beitler and J.R. Justin, Red cell aggregation as a cause of blood-flow echogenicity, Radiology 148 (1983), 799-802.
18. P. Siostrzonek, R. Koppensteiner, H. Gossinger, M. Zangeneh, G. Heinz, G. Kreiner, A. Stumpften, P. Buxbaum, H. Ehringer and H. Mosslacher, Hemodynamic and hemorheologic determinants of left atrial spontaneous echo contrast and thrombus formation in patients with idiopathic dilated cardiomyopathy, Am. Heart J. 125 (1993), 430-434.
19. Stroke Prevention in Atrial Fibrillation Investigators, Stroke prevention in atrial fibrillation study: final results, Circulation 84(1991),527-539.
20. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators, The effect of low dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation, New Engl.. J. Med. 323 (1990), 1505-1511.
21. L.M. Tsai, J.H. Chen, C.J. Fang, L.J. Lin and C.M. Kwan, Clinical implications of left atrial spontaneous echo contrast in nonrheumatic atrial fibrillation, Am. J. Cardiol. 70 (1992), 327-331.
22. M. Uno, H. Tsuji, S. Sawada, T. Toyoda and M. Nakagawa, Fibrinopeptidc A (FPA) levels in atrial fibrillation and the effects of heparin administration, Jpn. Circ. J. 52 (1988), 9-12.
23. P.A. Wolf, T.R. Dawber, E. Thomas, Jr. and W.B. Kannel, Epidemiologie assessment of chronic atrial fibrillation and risk of stroke: the Framingham study, Neurology 28 (1978), 973-977.